Development and Characterization of COVID-19 vaccine candidate

The goal of this study will be to characterize a SARS-CoV2 antigen and the formulated drug product that will contain SARS-CoV2 antigen and a squalene-based adjuvant under tight timeline to release the material for COVID-19 vaccine clinical trials.

Intern: 
Gabriella Gerzon
Faculty Supervisor: 
Yi Sheng;Paola Battiston
Province: 
Ontario
University: 
Partner: 
Partner University: 
Discipline: 
Program: